North America Healthcare Cold Chain Logistics Market Report by Product (Biopharmaceuticals, Vaccines, Clinical Trials), Segment (Transportation, Packaging, Instrumentation), and Country 2025-2033
The North America healthcare cold chain logistics market size reached USD 7.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 10.1 Billion by 2033, exhibiting a growth... もっと見る
SummaryThe North America healthcare cold chain logistics market size reached USD 7.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 10.1 Billion by 2033, exhibiting a growth rate (CAGR) of 3.9% during 2025-2033. The increasing cellular therapies and biomarker testing, escalating need to reduce wastage and financial losses, and surging demand for vaccines to treat numerous diseases among individuals represent some of the key factors driving the market.Healthcare cold chain logistics refers to the specialized handling, transportation, and storage of temperature-sensitive pharmaceuticals, vaccines, and biologics to ensure their integrity and efficacy. It involves the use of temperature-controlled environments and equipment throughout the supply chain to maintain the required temperature range and prevent any deviations that could compromise the quality of healthcare products. Cold chain logistics is crucial for preserving the potency and safety of temperature-sensitive healthcare products, as they can be sensitive to temperature variations. It encompasses various activities, including packaging, transportation, monitoring, and quality control, to ensure that these products are maintained within the required temperature conditions from manufacturing to end-use, safeguarding patient health and medication effectiveness. The increasing demand for temperature-sensitive pharmaceuticals, biologics, and vaccines, coupled with advancements in medical research and biotechnology, has contributed to the uptake of healthcare cold chain logistics in North America. These temperature-sensitive healthcare products require specialized handling and transportation to maintain their efficacy and safety. Moreover, the implementation of stringent regulatory requirements and quality standards imposed by regulatory bodies, such as the U.S. Food and Drug Administration (FDA), have reinforced the importance of maintaining proper temperature controls throughout the supply chain. This, in turn, has accelerated the product adoption rate. Additionally, the increasing complexity and globalization of the pharmaceutical and healthcare supply chains have led to a greater emphasis on end-to-end visibility and traceability. Furthermore, the rise of personalized medicine and biopharmaceuticals has augmented the demand for cold chain logistics, propelling the market growth. North America Healthcare Cold Chain Logistics Market Trends/Drivers: Increase in Demand for Biologics and Specialty Pharmaceuticals The increasing demand for biologics and specialty pharmaceuticals will stimulate the growth of the market in North America. Biologics, including vaccines, gene therapies, and monoclonal antibodies, are complex and delicate products that often require specific temperature conditions to maintain their efficacy. Similarly, specialty pharmaceuticals, such as oncology drugs and immunosuppressants, are often temperature-sensitive and require precise handling throughout the supply chain. The growing adoption of personalized medicine, advancements in biotechnology, and the development of innovative therapies are driving the demand for these specialized pharmaceutical products. As a result, there is an increased need for reliable cold chain logistics services that can ensure the integrity and potency of these temperature-sensitive products. Rise in Need for Regulatory Compliance Stringent regulatory compliance is another key driver for the market. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and Health Canada, have established stringent guidelines and regulations to ensure the safety, quality, and efficacy of pharmaceuticals and healthcare products. These regulations mandate proper temperature control and traceability throughout the supply chain to prevent the degradation or compromise of temperature-sensitive products. Adhering to these regulatory requirements is crucial for pharmaceutical manufacturers, distributors, and healthcare providers to maintain compliance and ensure patient safety. To meet these regulations, organizations often rely on specialized cold chain logistics providers that have the expertise, infrastructure, and capabilities to maintain strict temperature controls, implement temperature monitoring systems, and provide real-time visibility and traceability. North America Healthcare Cold Chain Logistics Industry Segmentation: IMARC Group provides an analysis of the key trends in each segment of the North America healthcare cold chain logistics market report, along with forecasts at the regional and country levels from 2025-2033. Our report has categorized the market based on product and segment. Breakup by Product: ? Biopharmaceuticals ? Vaccines ? Clinical Trials Vaccines represents the most popular product The report has provided a detailed breakup and analysis of the market based on the product. This includes biopharmaceuticals, vaccines, and clinical trials. According to the report, vaccines represented the largest segment. Vaccines serve as the dominating product in the market due to several key factors. Moreover, the rising importance of vaccines in preventing and controlling infectious diseases has augmented the product demand. Additionally, vaccines play a vital role in public health by safeguarding individuals and communities from various diseases. In line with this, the rising need for timely and reliable distribution of vaccines necessitates a robust cold chain logistics infrastructure to maintain the required temperature conditions and ensure vaccine efficacy is propelling the segment growth. Furthermore, regulatory requirements and stringent quality standards set by regulatory bodies like the U.S. Food and Drug Administration (FDA) demand strict adherence to cold chain protocols. Compliance with these regulations ensures that vaccines maintain their potency and safety throughout the distribution process. Breakup by Segment: ? Transportation ? Packaging ? Instrumentation Transportation accounts for the majority of the market share A detailed breakup and analysis of the market based on the segment has also been provided in the report. This includes transportation, packaging, and instrumentation. According to the report, transportation accounted for the largest market share. Transportation serves as the dominating segment in the market due to the geographical vastness of the North America region necessitates extensive transportation networks that ensure timely and efficient delivery of temperature-sensitive healthcare products is propelling the segment growth. Besides this, the transportation segment plays a critical role in connecting various nodes of the cold chain, including manufacturing facilities, cold storage centers, healthcare facilities, and distribution points. Furthermore, the increasing demand for healthcare products, particularly temperature-sensitive pharmaceuticals, and biologics, has augmented the need for reliable transportation services. These products require specialized handling and strict temperature control during transit to maintain their efficacy and safety. The transportation segment must ensure seamless and continuous cold chain operations to preserve the integrity of these products throughout the supply chain. Breakup by Country: ? United States ? Canada ? Mexico United States hold the largest share in the market The report has also provided a comprehensive analysis of all the major regional markets, which includes United States, Canada, and Mexico. According to the report, United States was the largest market for healthcare cold chain logistics in North America. Some of the factors driving the market included the growing prevalence of lifestyle diseases among individuals, increasing cross-border trades, and the rising need to reduce wastage of medical products. The size and complexity of the healthcare industry in the U.S. contribute to its dominance. The country has a large population, high healthcare expenditure, and advanced healthcare infrastructure, which has augmented demand for temperature-sensitive pharmaceuticals, vaccines, and biologics. This demand drives the need for robust cold chain logistics services to ensure the safe and efficient delivery of these products. Moreover, the presence of major pharmaceutical manufacturers and biotech companies in the United States is positively influencing the market growth. The country is also home to numerous leading healthcare and pharmaceutical companies that require reliable cold chain logistics for their products. These companies often have extensive distribution networks, making the U.S. a crucial hub for cold chain logistics operations. Furthermore, regulatory compliance and quality standards set by organizations like the U.S. Food and Drug Administration (FDA) is contributing to the market growth. Competitive Landscape: The key players in the market have made several innovations and advancements to meet the evolving demands of consumers and businesses. Market players have introduced advanced temperature monitoring systems that utilize sensors, data loggers, and real-time monitoring technology to track and monitor temperature conditions during transportation and storage. In addition, key players are developing specialized thermal packaging, insulated containers, and phase-change materials to maintain consistent temperature control and protect products from external temperature fluctuations. These packaging solutions help ensure the stability and quality of healthcare products throughout the cold chain. Additionally, the rising number of strategic collaborations and partnerships between logistics providers, pharmaceutical manufacturers, and regulatory bodies to streamline cold chain processes and ensure compliance with regulatory requirements is supporting the market growth. The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Key Questions Answered in This Report 1.What was the size of the North America healthcare cold chain logistics market in 2024? 2.What is the expected growth rate of the North America healthcare cold chain logistics market during 2025-2033? 3.What are the key factors driving the North America healthcare cold chain logistics market? 4.What has been the impact of COVID-19 on the North America healthcare cold chain logistics market? 5.What is the breakup of the North America healthcare cold chain logistics market based on the product? 6.What is the breakup of the North America healthcare cold chain logistics market based on the segment? 7.What are the key regions in the North America healthcare cold chain logistics market? Table of Contents1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Healthcare Cold Chain Logistics Market 5.1 Market Performance 5.2 Market Breakup by Product 5.3 Market Breakup by Segment 5.4 Market Breakup by Region 5.5 Market Forecast 6 North America Healthcare Cold Chain Logistics Market 6.1 Market Performance 6.2 Impact of COVID-19 6.3 Market Forecast 7 North America Healthcare Cold Chain Logistics Market: Breakup by Product 7.1 Biopharmaceuticals 7.2 Vaccines 7.3 Clinical Trials 8 North America Healthcare Cold Chain Logistics Market: Breakup by Segment 8.1 Transportation 8.2 Packaging 8.3 Instrumentation 9 North America Healthcare Cold Chain Logistics Market: Breakup by Country 9.1 United States 9.1.1 Historical Market Trends 9.1.2 Market Breakup by Product 9.1.3 Market Breakup by Segment 9.1.4 Market Forecast 9.2 Canada 9.2.1 Historical Market Trends 9.2.2 Market Breakup by Product 9.2.3 Market Breakup by Segment 9.2.4 Market Forecast 9.3 Mexico 9.3.1 Historical Market Trends 9.3.2 Market Breakup by Product 9.3.3 Market Breakup by Segment 9.3.4 Market Forecast 10 SWOT Analysis 10.1 Overview 10.2 Strengths 10.3 Weaknesses 10.4 Opportunities 10.5 Threats 11 Value Chain Analysis 11.1 Overview 11.2 Drug Production Facility 11.3 Refrigerated Warehouse 11.4 Transport (Air/Sea/Road/Rail) 11.5 Distribution Centres 11.6 Transport (Road) 11.7 End-Users 12 Porter’s Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Rivalry 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players List of Tables/GraphsList of FiguresFigure 1: North America: Healthcare Cold Chain Logistics Market: Major Drivers and Challenges Figure 2: Global: Healthcare Cold Chain Logistics Market: Sales Value (in Billion USD), 2019-2024 Figure 3: Global: Healthcare Cold Chain Logistics Market: Breakup by Product (in %), 2024 Figure 4: Global: Healthcare Cold Chain Logistics Market: Breakup by Segment (in %), 2024 Figure 5: Global: Healthcare Cold Chain Logistics Market: Breakup by Region (in %), 2024 Figure 6: Global: Healthcare Cold Chain Logistics Market Forecast: Sales Value (in Billion USD), 2025-2033 Figure 7: North America: Healthcare Cold Chain Logistics Market: Sales Value (in Billion USD), 2019-2024 Figure 8: North America: Healthcare Cold Chain Logistics Market Forecast: Sales Value (in Billion USD), 2025-2033 Figure 9: North America: Healthcare Cold Chain Logistics Market: Breakup by Product (in %), 2024 Figure 10: North America: Healthcare Cold Chain Logistics (Biopharmaceuticals) Market: Sales Value (in Million USD), 2019 & 2024 Figure 11: North America: Healthcare Cold Chain Logistics (Biopharmaceuticals) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 12: North America: Healthcare Cold Chain Logistics (Vaccines) Market: Sales Value (in Million USD), 2019 & 2024 Figure 13: North America: Healthcare Cold Chain Logistics (Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 14: North America: Healthcare Cold Chain Logistics (Clinical Trials) Market: Sales Value (in Million USD), 2019 & 2024 Figure 15: North America: Healthcare Cold Chain Logistics (Clinical Trials) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 16: North America: Healthcare Cold Chain Logistics Market: Breakup by Segment (in %), 2024 Figure 17: North America: Healthcare Cold Chain Logistics (Transportation) Market: Sales Value (in Million USD), 2019 & 2024 Figure 18: North America: Healthcare Cold Chain Logistics (Transportation) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 19: North America: Healthcare Cold Chain Logistics (Packaging) Market: Sales Value (in Million USD), 2019 & 2024 Figure 20: North America: Healthcare Cold Chain Logistics (Packaging) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 21: North America: Healthcare Cold Chain Logistics (Instrumentation) Market: Sales Value (in Million USD), 2019 & 2024 Figure 22: North America: Healthcare Cold Chain Logistics (Instrumentation) Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 23: North America: Healthcare Cold Chain Logistics Market: Breakup by Country (in %), 2024 Figure 24: United States: Healthcare Cold Chain Logistics Market: Sales Value (in Million USD), 2019-2024 Figure 25: United States: Healthcare Cold Chain Logistics Market: Breakup by Product (in %), 2024 Figure 26: United States: Healthcare Cold Chain Logistics Market: Breakup by Segment (in %), 2024 Figure 27: United States: Healthcare Cold Chain Logistics Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 28: Canada: Healthcare Cold Chain Logistics Market: Sales Value (in Million USD), 2019-2024 Figure 29: Canada: Healthcare Cold Chain Logistics Market: Breakup by Product (in %), 2024 Figure 30: Canada: Healthcare Cold Chain Logistics Market: Breakup by Segment (in %), 2024 Figure 31: Canada: Healthcare Cold Chain Logistics Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 32: Mexico: Healthcare Cold Chain Logistics Market: Sales Value (in Million USD), 2019-2024 Figure 33: Mexico: Healthcare Cold Chain Logistics Market: Breakup by Product (in %), 2024 Figure 34: Mexico: Healthcare Cold Chain Logistics Market: Breakup by Segment (in %), 2024 Figure 35: Mexico: Healthcare Cold Chain Logistics Market Forecast: Sales Value (in Million USD), 2025-2033 Figure 36: North America: Healthcare Cold Chain Logistics Industry: SWOT Analysis Figure 37: North America: Healthcare Cold Chain Logistics Industry: Value Chain Analysis Figure 38: North America: Healthcare Cold Chain Logistics Industry: Porter’s Five Forces Analysis List of Tables Table 1: North America: Healthcare Cold Chain Logistics Market: Key Industry Highlights, 2024 and 2033 Table 2: North America: Healthcare Cold Chain Logistics Market Forecast: Breakup by Product (in Million USD), 2025-2033 Table 3: North America: Healthcare Cold Chain Logistics Market Forecast: Breakup by Segment (in Million USD), 2025-2033 Table 4: North America: Healthcare Cold Chain Logistics Market Forecast: Breakup by Country (in Million USD), 2025-2033 Table 5: North America: Healthcare Cold Chain Logistics Market: Competitive Structure Table 6: North America: Healthcare Cold Chain Logistics Market: Key Players
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(運輸)の最新刊レポート
IMARC Services Private Limited.社の 交通・ロジスティクス分野 での最新刊レポート
本レポートと同じKEY WORD(healthcare)の最新刊レポート
よくあるご質問IMARC Services Private Limited.社はどのような調査会社ですか?インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|